Remus Pharmaceuticals (NSE:REMUS) Land And Improvements : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Land And Improvements?

Remus Pharmaceuticals's land and improvements for the quarter that ended in Mar. 2025 was ₹0 Mil.

Remus Pharmaceuticals Land And Improvements Historical Data

The historical data trend for Remus Pharmaceuticals's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Land And Improvements Chart

Remus Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar24

Mar25

Land And Improvements

Remus Pharmaceuticals Semi-Annual Data
	Mar20	Mar21	Mar22	Sep23	Mar24	Sep24	Mar25
Land And Improvements	Get a 7-Day Free Trial			-	-	-	-	-

Remus Pharmaceuticals Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Remus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054

Website

https://www.remuspharma.com

Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines